 Thank you Ian. Our next speaker is from the Green Party. He is someone who has been a passionate advocate for change in drug reform for many, many years. Ladies and gentlemen, Kevin Haig. Good afternoon everyone. It's great to be here. So I'm the Green Party's health spokesperson and have a bit of a background in the health sector. Trying to understand New Zealand's regulation of drugs is largely an exercise in what I would call legal paleontology. So rather than a single, coherent framework, we instead have a wide variety of different approaches that are effectively fossils of the culture and values of the era in which they were developed. And it will be no surprise to you, I think, that the Green Party favours instead the adoption of a single, coherent framework. One that's based on health rather than justice. One that's based on minimising harm. One that is evidence-based. And one that seeks to regulate drugs, I used the term in the broadest sense, in proportion to the risk to health that they pose. So proportionate. It's also crucial to balance our collective responsibility to produce public good by minimising health-related harm with individual autonomy. So when I sat in my friend's lounge the other night and drank four gin on tonics, I was taking a step quite deliberately that I knew carried the risk of harm to myself. But I also derived quite a lot of utility from that action. So there could be some economists in the room. And that's the same balancing act, the same calculation that I make when I go mountain biking. And so the New Zealand regulatory framework for drugs needs to balance those two things, individual autonomy against the public good. So far, everything I've said has been commonplace and I could have said it at a conference like this 20 years ago. So there's nothing new in anything that I've said. But in the last, I would say, year, maybe a bit more than the year, there have been three really big important steps that have totally changed the landscape. I don't know, you've heard a lot about those things. One is what's been happening internationally and I guess the experience of Uruguay and Colorado and Washington and others has all been part of that landscape. The second thing is the Cycractive Substances Act, which puts in place the basics of the kind of framework that I have been talking about. And then the third thing, which I think is very important and I don't know if you've discussed it here today, is the consensus declaration from the conference that the New Zealand Drug Foundation hosted last year. Now, I think what has to happen now is that that consensus statement needs to form the basis of the national policy statement that's currently being developed. The Cycractive Substances Act has got to be made to work and to demonstrate harm reduction so that we are able to build on it. And the third thing that I identify is that we need to get drug reform organisations to actually work together to a coherent strategy, which hasn't been happening all that well until now. But meetings like this are a fantastic opportunity to build on that. So, I'm getting the wind up. Opportunity is starting to take shape in front of us. It's coalescing really, really fast and those of us who are interested in law reform now need to be able to act quickly to take advantage of that opportunity. Thank you.